Unknown

Dataset Information

0

TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.


ABSTRACT: Aberrant activation of the renin-angiotensin-aldosterone system (RAAS) contributes to adverse cardiac remodeling and eventual failure. Here we investigated whether TRAF3 Interacting Protein 2 (TRAF3IP2), a redox-sensitive cytoplasmic adaptor molecule and an upstream regulator of nuclear factor-?B (NF-?B) and activator protein-1 (AP-1), mediates aldosterone-induced cardiac hypertrophy and fibrosis. Wild type (WT) and TRAF3IP2-null mice were infused with aldosterone (0.2 mg/kg/day) for 4 weeks along with 1%NaCl in drinking water. Aldosterone/salt, but not salt alone, upregulated TRAF3IP2 expression in WT mouse hearts. Further, aldosterone elevated blood pressure to a similar extent in both WT and TRAF3IP2-null groups. However, TRAF3IP2 gene deletion attenuated aldosterone/salt-induced (i) p65 and c-Jun activation, (ii) extracellular matrix (collagen I?1 and collagen III?1), matrix metalloproteinase (MMP2), lysyl oxidase (LOX), inflammatory cytokine (IL-6 and IL-18), chemokine (CXCL1 and CXCL2), and adhesion molecule (ICAM1) mRNA expression in hearts, (iii) IL-6, IL-18, and MMP2 protein levels, (iv) systemic IL-6 and IL-18 levels, and (iv) cardiac hypertrophy and fibrosis. These results indicate that TRAF3IP2 is a critical signaling intermediate in aldosterone/salt-induced myocardial hypertrophy and fibrosis, and thus a potential therapeutic target in hypertensive heart disease.

SUBMITTER: Sakamuri SS 

PROVIDER: S-EPMC4861697 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC2803144 | BioStudies
2016-01-01 | S-EPMC5016681 | BioStudies
2018-01-01 | S-EPMC6336952 | BioStudies
2017-01-01 | S-EPMC5659692 | BioStudies
2016-01-01 | S-EPMC4701403 | BioStudies
2018-01-01 | S-EPMC6732793 | BioStudies
2013-01-01 | S-EPMC3793247 | BioStudies
2017-06-15 | GSE87122 | GEO
2010-01-01 | S-EPMC2917526 | BioStudies
2019-01-01 | S-EPMC6802004 | BioStudies